Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N8BA
|
|||
Drug Name |
Bicyclic pyrimidine derivative 2
|
|||
Synonyms |
PMID27718763-Compound-4
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H20F4N4O3
|
|||
Canonical SMILES |
CC1(CN2C(=CC(=NC2=O)OCC3=CC(=C(C=C3)OC4=CN=CC(=C4)C(F)(F)F)F)N1C)C
|
|||
InChI |
1S/C22H20F4N4O3/c1-21(2)12-30-19(29(21)3)8-18(28-20(30)31)32-11-13-4-5-17(16(23)6-13)33-15-7-14(9-27-10-15)22(24,25)26/h4-10H,11-12H2,1-3H3
|
|||
InChIKey |
PPKNPJKYLRQSCE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Platelet-activating factor acetylhydrolase (PLA2G7) | Target Info | Inhibitor | [1] |
Target's Patent Info | Platelet-activating factor acetylhydrolase (PLA2G7) | Target's Patent Info | [1] | |
KEGG Pathway | Ether lipid metabolism | |||
Metabolic pathways | ||||
Biosynthesis of antibiotics | ||||
Pathway Interaction Database | Lissencephaly gene (LIS1) in neuronal migration and development | |||
WikiPathways | IL1 and megakaryotyces in obesity | |||
Synthesis, Secretion, and Deacylation of Ghrelin |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016).Expert Opin Ther Pat. 2017 Feb;27(2):217-225. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.